Skip to content

Understanding the Increased Risk of Atrial Fibrillation in Athletes: a Case-control Study

Understanding the Increased Risk of Atrial Fibrillation in Athletes: a Case-control Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06844656
Acronym
AFLETES-ECG
Enrollment
200
Registered
2025-02-25
Start date
2025-02-28
Completion date
2026-10-10
Last updated
2025-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation (AF)

Keywords

Atrial Fibrillation, Athletes, Sport, Physical Activity, Exercise, Arrhythmias

Brief summary

Exercise is beneficial to heart health, however, there appears to be a 'U' shaped relationship where too much exercise may increase the risk of an irregular heart rhythm, called atrial fibrillation. Endurance athletes may have up to a 2.5-fold higher risk of developing atrial fibrillation than non-athletic controls. The mechanisms behind this increased risk of atrial fibrillation are not the well understood. It is thought to be a mixture of enlarged heart chambers, low resting heart rate, genetic predisposition and possibly scarring in the heart. In this study, the investigators will investigate the electrical activity changes in the heart, using a high-quality electrocardiogram (ECG) and relate this to changes in the heart size measured by ultrasound and MRI. Cardiopulmonary exercise testing will determine fitness (V̇O2 max) and assess the heart's electrical activity during exercise. This will be a case-control study where athletes with and without atrial fibrillation will be recruited. The investigators hope the results of this study can improve our understanding of atrial fibrillation in athletes by associating atrial fibrillation with structural and electrical differences which may aid the prediction of future atrial fibrillation development and help guide more athlete-specific treatment pathways.

Interventions

None listed

Sponsors

University of Leicester
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* ≥18 years of age at the time of enrolment, male and female. * History of atrial fibrillation confirmed on ECG - either paroxysmal or persistent. * Competitive athlete. Defined as: 1. Competed in endurance sports with a total cumulative moderate to high intensity of \> 1500 hours. 2. Have participated in at least one competitive event in the last 10 years.

Exclusion criteria

* Permanent atrial fibrillation. * History of pre-existing cardiovascular disease : 1. Atherosclerotic disease: previous myocardial infarction, symptomatic coronary artery disease or Peripheral peripheral arterial disease 2. Left ventricular systolic dysfunction (EF \< 45%) 3. Heart muscle disease: cardiomyopathies, Infiltrative diseases of the heart 4. Complex Congenital heart disease 5. Moderate or severe valvular disease 6. Uncontrolled hypertension (\>180/100mmHg)

Design outcomes

Primary

MeasureTime frameDescription
High-resolution ECGAt study visitUsing high quality ECG, assess whether subtle differences can be detected in athletes with AF, compared to athletes without AF, and whether machine learning could predict new-onset AF. Detection of subtle differences in p wave parameters (duration, amplitude, dispersion, PTFV1) in athletes with AF compared to athletes without AF. AUC, specificity and sensitivity.

Secondary

MeasureTime frameDescription
72hr heart rate monitoringAt study visitCompare autonomic tone via heart rate variability from 72-hour continuous ECG monitoring in athletes with and without AF. Analysis of RR intervals from heart rate variability.
Electronic stethoscope recordingAt study visitCompare the heart sounds using electronic stethoscope in athletes with and without AF. S1 and S2 sounds of heart valves.
AI classification and predictionAt study visitAssess the accuracy of using machine learning to identify athletes with AF using ECG data. AUC, specificity and sensitivity of machine learning identification of AF.
Cardiopulmonary exercise testingAt study visitPeak VO2
Cardiac motion recordingAt study visitCardiac angular velocity
Cardiac imagingAt study visitLeft ventricular mass

Countries

United Kingdom

Contacts

Primary ContactCai L Davies
cld43@leicester.ac.uk+447765791818

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026